Freeline Therapeutics Holdings plc Quarterly Employee-related Liabilities, Current in USD from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Freeline Therapeutics Holdings plc quarterly Employee-related Liabilities, Current history and growth rate from Q4 2019 to Q3 2023.
  • Freeline Therapeutics Holdings plc Employee-related Liabilities, Current for the quarter ending September 30, 2023 was $2.74M, a 31.3% decline year-over-year.
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $2.74M -$1.25M -31.3% Sep 30, 2023 6-K 2023-12-01
Q2 2023 $2.43M -$934K -27.8% Jun 30, 2023 6-K 2023-08-15
Q1 2023 $2.49M -$915K -26.9% Mar 31, 2023 6-K 2023-05-30
Q4 2022 $4.18M -$376K -8.26% Dec 31, 2022 6-K 2023-12-01
Q3 2022 $3.99M -$1.26M -24% Sep 30, 2022 6-K 2022-11-15
Q2 2022 $3.36M -$728K -17.8% Jun 30, 2022 6-K 2022-08-09
Q1 2022 $3.41M +$220K +6.91% Mar 31, 2022 6-K 2022-05-10
Q4 2021 $4.55M -$246K -5.13% Dec 31, 2021 20-F 2023-04-04
Q3 2021 $5.25M Sep 30, 2021 6-K 2021-11-09
Q2 2021 $4.09M +$2.19M +115% Jun 30, 2021 6-K 2021-08-16
Q1 2021 $3.19M Mar 31, 2021 6-K 2021-05-17
Q4 2020 $4.8M +$2.38M +98.4% Dec 31, 2020 20-F 2022-03-31
Q2 2020 $1.9M Jun 30, 2020 6-K 2020-10-29
Q4 2019 $2.42M Dec 31, 2019 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.